Citation Impact
Citing Papers
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2009
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
2008 Standout
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
Lapatinib plus Letrozole as First-Line Therapy for HER-2+ Hormone Receptor–Positive Metastatic Breast Cancer
2010
Targeted Therapy in Breast Cancer
2004
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Hypoxia — a key regulatory factor in tumour growth
2002 Standout
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Direct Measurement of the Wigner Function of a One-Photon Fock State in a Cavity
2002 StandoutNobel
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Endocrinology: Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy
1996
Necroptosis and its role in inflammation
2015 StandoutNature
Simple and compact 1-Hz laser system via an improved mounting configuration of a reference cavity
2005 StandoutNobel
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
2006 Standout
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Ductal Carcinoma in Situ of the Breast: a New Phenotype Classification System and its Relation to Prognosis
2002
Naturally occurring B-cell responses to breast cancer
2003
A Randomized Trial Comparing Axillary Dissection to No Axillary Dissection in Older Patients With T1N0 Breast Cancer
2005
Immunogenic cell death in cancer and infectious disease
2016 Standout
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
2012 StandoutNature
The molecular biology of head and neck cancer
2010 Standout
Second line chemotherapy for NSCLC: establishing a gold standard
2002
EGF–ERBB signalling: towards the systems level
2006 Standout
Estrogen Receptor–Positive, Progesterone Receptor–Negative Breast Cancer: Association With Growth Factor Receptor Expression and Tamoxifen Resistance
2005
Exploiting tumour hypoxia in cancer treatment
2004 Standout
Light Diffraction by a Strong Standing Electromagnetic Wave
2006
Amplification of Ultrashort Laser Pulses by Brillouin Backscattering in Plasmas
2013 StandoutNobel
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Pair Creation in QED-Strong Pulsed Laser Fields Interacting with Electron Beams
2010 StandoutNobel
Male breast cancer
2006 Standout
Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study
2001
Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma
2003
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
2011 Standout
Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis
2011 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
The effect of symptom clusters on functional status and quality of life in women with breast cancer
2009
<i>HER2</i> Evaluation and Its Impact on Breast Cancer Treatment Decisions
2011
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
The 17q12-q21 amplicon: Her2 and topoisomerase-IIα and their importance to the biology of solid tumours
2006
Microtubules as a target for anticancer drugs
2004 Standout
A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC)
2000
Prognostic molecular markers in early breast cancer
2004
Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial
2002 Standout
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Cancer and the chemokine network
2004 Standout
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells
2007
Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer
2005
Breast cancer metastasis: markers and models
2005 Standout
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Gemcitabine Plus Vinorelbine Versus Vinorelbine Alone in Elderly Patients With Advanced Non–Small-Cell Lung Cancer
2000
Tirapazamine Plus Cisplatin Versus Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Report of the International CATAPULT I Study Group
2000
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
2006 Standout
Squeezed vacuum from a monolithic optical parametric oscillator
1995
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
2005 Standout
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
1992 Standout
The ELVIS Trial: A Phase III Study of Single-Agent Vinorelbine as First-Line Treatment in Elderly Patients with Advanced Non-Small Cell Lung Cancer
2001
Ring-laser tests of fundamental physics and geophysics
1997
Childbearing issues in breast carcinoma survivors
1997
The HER-2/neu Gene and Protein in Breast Cancer 2003: Biomarker and Target of Therapy
2003
Nonlinear collective effects in photon-photon and photon-plasma interactions
2006
Stromal Cell–Derived Factor-1α and CXCR4 Expression in Hemangioblastoma and Clear Cell-Renal Cell Carcinoma: von Hippel-Lindau Loss-of-Function Induces Expression of a Ligand and Its Receptor
2005 StandoutNobel
Phase-coherent amplification of atomic matter waves
1999 StandoutNatureNobel
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
Cancer Genome Landscapes
2013 StandoutScience
Sensitivity to dark energy candidates by searching for four-wave mixing of high-intensity lasers in the vacuum
2012
Prediction of axillary lymph node involvement of women with invasive breast carcinoma
1998
Measurement of mirror birefringence at the sub-ppm level: Proposed application to a test of QED
2000 StandoutNobel
Risk of Menopause During the First Year After Breast Cancer Diagnosis
1999
Second-line chemotherapy for non-small cell lung cancer
2002
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Measurement of a negative value for the Wigner function of radiation
2000 StandoutNobel
Works of Franco Perrone being referenced
Pathobiologic identification of two distinct breast carcinoma subsets with diverging clinical behaviors
1999
Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer.
2003
Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II study
1997
A predictive index of axillary nodal involvement in operable breast cancer
1996
Selecting high-risk early breast cancer patients: What to add to the number of metastatic nodes?
1996
Prolactin receptor does not correlate with oestrogen and progesterone receptors in primary breast cancer and lacks prognostic significance. Ten year results of the Naples adjuvant (GUN) study
1990
Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer
1991
Experimental method to detect the magnetic birefringence of vacuum
1998
Single-agent gemcitabine as second-line treatment in patients with advanced non small cell lung cancer (NSCLC): a phase II trial.
2000
PVLAS: Vacuum Birefringence and production and detection of nearly massless, weakly coupled particles by optical techniques.
1994
Vinorelbine (VNR) plus best supportive care (BSC) vs. BSC in the treatment of advanced non-small cell lung cancer (NSCLC) elderly patients (PTS). Results of a phase III randomized trial
1998
Search for stimulated photon-photon scattering in vacuum
2000
Time trends of consumption and costs of drugs in a cancer referral centre
1997
Frequency locking of a Nd:YAG laser using the laser itself as the optical phase modulator
1995
Measurement of the phase anisotropy of very high reflectivity interferential mirrors
1997